Incidence, clinical features, and risk factors of fluoroquinolone-induced acute liver injury: a case-control study

References

• SousaJAlvesGFortunaAFalcaoAThird and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profilesCurr Drug Saf2014928910524410307
   PubMedGoogle Scholar
• OwensRCAmbrosePGAntimicrobial safety: focus on fluoroquinolonesClin Infect Dis200541Suppl 2S144S15715942881
   PubMed Web of Science ®Google Scholar
• OrmanESConjeevaramHSVuppalanchiRClinical and histopathologic features of fluoroquinolone-induced liver injuryClin Gastroenterol Hepatol201196517523.e321356330
   PubMed Web of Science ®Google Scholar
• LicataARandazzoCMorrealeIButeraGD’AlessandroNCraxìAFluoroquinolone-induced liver injury: three new cases and a review of the literatureEur J Clin Pharmacol201268552553222246188
   PubMed Web of Science ®Google Scholar
• DuggiralaAJosephJSharmaSNuthetiRGargPDasTActivity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparisonIndian J Ophthalmol2007551151917189881
   PubMedGoogle Scholar
• LubaschAKellerIBornerKKoeppePLodeHComparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteersAntimicrob Agents Chemother200044102600260310991830
   PubMed Web of Science ®Google Scholar
• SotoSLópez-RosésLAvilaSMoxifloxacin-induced acute liver injuryAm J Gastroenterol200297718531854
   PubMed Web of Science ®Google Scholar
• KayeJACastellsagueJBuiCLRisk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort studyPharmacotherapy201434433634924865821
   PubMed Web of Science ®Google Scholar
• LevineCTrivediAThungSNPerumalswamiPVSevere ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and reviewSemin Liver Dis201434224625124879988
   PubMed Web of Science ®Google Scholar
• GulenMAyMOAvciAAcikalinAIcmeFLevofloxacin-induced hepatotoxicity and deathAm J Ther2015223e93e9624067876
   PubMed Web of Science ®Google Scholar
• ChenCJiaWGuoDDevelopment of a computer-assisted adverse drug events alarm and assessment system for hospital inpatients in ChinaTher Innov Regul Sci201818216847901881019
   Google Scholar
• GuoDChangSUWangXResearch and practice of Informationalized automatic monitoring on inpatients with Drug-induced liver injuryEval Anal Drug-Use Hosp China20171710191021
   Google Scholar
• AithalGPWatkinsPBAndradeRJCase definition and phenotype standardization in drug-induced liver injuryClin Pharmacol Ther201189680681521544079
   PubMed Web of Science ®Google Scholar
• FontanaRJWatkinsPBBonkovskyHLDrug-induced liver injury network (DILIN) prospective study: rationale, design and conductDrug Saf2009321556819132805
   PubMed Web of Science ®Google Scholar
• KimSHNaisbittDJUpdate on advances in research on idiosyncratic drug-induced liver injuryAllergy Asthma Immunol Res20168131126540496
   PubMed Web of Science ®Google Scholar
• AlshammariTMLarratEPMorrillHJCaffreyARQuilliamBJLaplanteKLRisk of hepatotoxicity associated with fluoroquinolones: a National Case-Control Safety StudyAm J Health Syst Pharm2014711374324352180
   PubMed Web of Science ®Google Scholar
• SunQZhangQGuJPrevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort studyPharmacoepidemiol Drug Saf201625890891726935778
   PubMed Web of Science ®Google Scholar
• PatersonJMMamdaniMMMannoMJuurlinkDNCanadian Drug Safety and Effectiveness Research NetworkFluoroquinolone therapy and idiosyncratic acute liver injury: a population-based studyCMAJ2012184141565157022891208
   PubMed Web of Science ®Google Scholar
• van BambekeFTulkensPMSafety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classesDrug Saf200932535937819419232
   PubMed Web of Science ®Google Scholar
• MorenoLSánchez-DelgadoJVergaraMCasasMMiquelMDalmauBRecurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanicRev Esp Enferm Dig20151071276776826671593
   PubMed Web of Science ®Google Scholar
• UngerCAl-JashaamiLSCiprofloxacin exposure leading to fatal hepatotoxicity: an unusual correlationAm J Case Rep20161767668127653941
   PubMedGoogle Scholar
• SchlossMBecakDTostoSTVelayatiAA case of Levofloxacin-Induced hepatotoxicityAm J Case Rep20181927227629523775
   PubMed Web of Science ®Google Scholar
• SteuerwaldNMFoureauDMNortonHJProfiles of serum cytokines in acute drug-induced liver injury and their prognostic significancePLoS One2013812e8197424386086
   PubMed Web of Science ®Google Scholar
• LavertyHGAntoineDJBensonCChapondaMWilliamsDKevin ParkBThe potential of cytokines as safety biomarkers for drug-induced liver injuryEur J Clin Pharmacol2010661096197620694460
   PubMed Web of Science ®Google Scholar
• ChalasaniNBjörnssonERisk factors for idiosyncratic drug-induced liver injuryGastroenterology201013872246225920394749
   PubMed Web of Science ®Google Scholar
• ChalasaniNPHayashiPHBonkovskyHLNavarroVJLeeWMFontanaRJACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injuryAm J Gastroenterol2014109795096624935270
   PubMed Web of Science ®Google Scholar
• AhmadJOdinJAEpidemiology and genetic risk factors of drug hepatotoxicityClin Liver Dis2017211557227842775
   PubMed Web of Science ®Google Scholar
• AndradeRJTulkensPMHepatic safety of antibiotics used in primary careJ Antimicrob Chemother20116671431144621586591
   PubMed Web of Science ®Google Scholar
• BjörnssonESBergmannOMBjörnssonHKKvaranRBOlafssonSIncidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of IcelandGastroenterology201314471419142523419359
   PubMed Web of Science ®Google Scholar
• SinglaRSharmaSKMohanAEvaluation of risk factors for antituberculosis treatment induced hepatotoxicityIndian J Med Res2010132818620693595
   PubMed Web of Science ®Google Scholar
• BabalıkAArdaHBakırcıNManagement of and risk factors related to hepatotoxicity during tuberculosis treatmentTuberk Toraks201260213614422779934
   PubMedGoogle Scholar
• ChenMSuzukiABorlakJAndradeRJLucenaMIDrug-induced liver injury: interactions between drug properties and host factorsJ Hepatol201563250351425912521
   PubMed Web of Science ®Google Scholar
• Ortega-AlonsoAStephensCLucenaMAndradeRCase characterization, clinical features and risk factors in drug-induced liver injuryInt J Mol Sci2016175714
   PubMed Web of Science ®Google Scholar
• AlqahtaniSAKleinerDEGhabrilMIdentification and characterization of Cefazolin-Induced liver injuryClin Gastroenterol Hepatol201513713281336.e225528012
   PubMed Web of Science ®Google Scholar
• HaqueTSasatomiEHayashiPHDrug-induced liver injury: pattern recognition and future directionsGut Liver2016101273626696029
   PubMed Web of Science ®Google Scholar
• UrbanTJShenYStolzALimited contribution of common genetic variants to risk for liver injury due to a variety of drugsPharmacogenet Genomics2012221178479522968431
   PubMed Web of Science ®Google Scholar
• NicolettiPAithalGPBjornssonESAssociation of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association StudyGastroenterology201715251078108928043905
   PubMed Web of Science ®Google Scholar